|
SLBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.832500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.37469999994533E-06 |
| Normal-vs-Stage2 |
9.735300E-03 |
| Normal-vs-Stage3 |
1.887610E-02 |
| Normal-vs-Stage4 |
7.638000E-01 |
| Stage1-vs-Stage2 |
4.423600E-01 |
| Stage1-vs-Stage3 |
6.413900E-02 |
| Stage1-vs-Stage4 |
3.640000E-02 |
| Stage2-vs-Stage3 |
4.868200E-01 |
| Stage2-vs-Stage4 |
5.244100E-02 |
| Stage3-vs-Stage4 |
1.546970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.447990E-04 |
| Normal-vs-AfricanAmerican |
1.643080E-03 |
| Normal-vs-Asian |
6.648600E-01 |
| Caucasian-vs-AfricanAmerican |
4.450200E-01 |
| Caucasian-vs-Asian |
1.876560E-01 |
| AfricanAmerican-vs-Asian |
2.540400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5285899999995E-05 |
| Normal-vs-Female |
1.083030E-01 |
| Male-vs-Female |
2.815800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.383870E-03 |
| Normal-vs-Extreme_Weight |
2.32199999999905E-05 |
| Normal-vs-Obese |
1.178740E-03 |
| Normal-vs-Extreme_Obese |
8.178600E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.858000E-01 |
| Normal_Weight-vs-Obese |
7.640800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.654000E-01 |
| Extreme_Weight-vs-Obese |
1.855580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.186000E-01 |
| Obese-vs-Extreme_Obese |
4.298200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.023600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.351000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.993720E-04 |
| Normal-vs-Age(81-100Yrs) |
3.185900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.517360E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.414300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.788250E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.387400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.098820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.618610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.65169999975102E-07 |
| Normal-VS-Type2 PRCC |
3.172900E-04 |
| Normal-VS-KIRP CIMP |
1.508790E-01 |
| Normal-VS-Unclassified PRCC |
8.05350000000482E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.312800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.73620000004848E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
5.360800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.647450E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.623400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.644400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.21199999994592E-06 |
| Normal-vs-N1 |
6.556800E-01 |
| Normal-vs-N2 |
2.897400E-01 |
| N0-vs-N1 |
1.763210E-03 |
| N0-vs-N2 |
2.288400E-01 |
| N1-vs-N2 |
3.921200E-01 |
|
|
